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 The major virulence determinant of the rodent malaria parasite, Plasmodium yoelii, has remained unresolved since the 
discovery of the lethal line in the 1970s. As virulence in this parasite correlates with the ability to invade different types of 
erythrocytes, we evaluated the potential role of the parasite erythrocyte binding ligand, PyEBL. We found one amino acid 
substitution in a domain responsible for intracellular trafficking between the lethal and non-lethal parasite lines, and, 
furthermore, that the intracellular localization of PyEBL was distinct between these lines. Genetic modification showed that 
this substitution was responsible not only for PyEBL localization, but also the erythrocyte-type invasion preference of the 
parasite, and subsequently its virulence in mice. This previously unrecognized mechanism for altering an invasion phenotype 
indicates that subtle alterations of a malaria parasite ligand can dramatically affect host-pathogen interactions and malaria 
virulence. 
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The rodent malaria parasite Plasmodium yoelii yoelii has 
been widely studied in order to understand the interactions 
between the malaria parasite and the host-cell (1). The 
non-lethal 17X line mainly infects young erythrocytes 
(reticulocytes) whereas the lethal 17XL and YM lines 
infect a wide range of erythrocytes. These lines have 
previously been studied in order to identify the genetic 
determinants of virulence (2, 3). These differences in 
erythrocyte invasion preference suggest the possible 
involvement of a parasite ligand that recognizes 
erythrocyte surface receptors, however, the actual 
molecular basis of the observed invasion preference 
differences remains unclear. 
 Erythrocyte invasion by the malaria merozoite is a 
multistep process, initiated by reversible binding to the 
erythrocyte surface, followed by the establishment of a 
tight junction between the apical end of the merozoite and 
erythrocyte surface and the subsequent movement of the 
merozoite into the nascent parasitophorous vacuole. Each 
step involves specific interactions between parasite ligands 
and erythrocyte receptors. Among the ligands of malaria 
parasites, the best characterized is a type I integral 
transmembrane protein encoded by the ebl 
(erythrocyte-binding-like) gene family. Upon release from 
the micronemes, EBL proteins recognize erythrocyte 
receptors and initiate the formation of the tight junction. 
The importance of EBL in malaria virulence is exemplified 
in the human malaria parasite Plasmodium vivax which 
uses an EBL ortholog, PvDBP, to recognize the Duffy 
antigen on the erythrocyte surface. As the parasite is 
apparently unable to utilize an alternative invasion 
pathway, individuals in whom the Duffy antigen is not 
expressed on the erythrocyte surface are completely 
resistant to P. vivax (4, 5). Due to this dramatic association 
between the disruption of a host-pathogen interaction and 
protection against a malaria parasite, PvDBP and the 
Plasmodium falciparum EBL ortholog, EBA-175, have 
been targeted for vaccine development (6). 
 EBL proteins possess two Cys-rich regions conserved 
among EBL orthologs. The N-terminal Cys-rich region 
named the DBL (Duffy-Binding-Like) domain or Region 2 
(7) recognizes a specific erythrocyte surface receptor. The 
C-terminal Cys-rich region named the C-cys domain or 
Region 6 is located adjacent to the transmembrane domain 
and the number and location of Cys residues are well 
conserved among known Plasmodium species. Region 6 
exhibits structural similarity to the KIX-binding domain of 
the coactivator CREB-binding protein (8) and has been 
proposed to be a protein trafficking signal for 
transportation to the micronemes (9). Here we report a 
single non-synonymous nucleotide substitution in the 
pyebl gene between lethal and non-lethal lines of P. yoelii 
and show the effect of this substitution on the intracellular 
localization of EBL, erythrocyte-type preference and 
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 In order to investigate differences in EBL between 
lethal and non-lethal P. yoelii lines, we compared 
sequences from a variety of malaria parasite species and P. 
yoelii lines 17X, 17XL, and YM. We found one 
non-synonymous nucleotide substitution in Region 6 
between non-lethal 17X and lethal 17XL lines in the entire 
open reading frame (Fig. 1). The non-lethal 17X line 
possesses 8 conserved Cys residues that form 4 disulfide 
bridges (8), whereas the lethal 17XL line possesses an Arg 
instead of Cys at the second Cys position. This substitution 
was also found in another lethal line “YM” (2), which 
originated independently from the 17X line during serial 
passage (3). All Plasmodium EBL orthologs for which 
protein expression was validated possess 8 conserved Cys 
residues in this region, further indicating that these Cys 
residues play an important role (Fig. S1). Thus the 
observed substitution from Cys to Arg is likely to abolish 
the native conformation of Region 6. 
 
EBL localizes in the dense granules in P. yoelii line 
17XL. We raised specific polyclonal and monoclonal 
antibodies against PyEBL and performed Western blot 
analysis. The PyEBL protein was detected as a 110-kDa 
band in both the 17X and 17XL lines (Fig. 2A). The 
intracellular localization of PyEBL in both the 17X and 
17XL lines was compared by indirect immunofluorescent 
assay (IFA) using specific antibodies against PyEBL (Fig. 
S2). In the 17X line, PyEBL localized to the apical end of 
each merozoite in both the segmented schizont-stage 
parasite and individual merozoites where it colocalized 
with AMA1, a known microneme protein, under 
immunofluorescent microscopy (Fig. 2B). However, in the 
17XL line PyEBL did not colocalize with AMA1 at the 
apical end of merozoites and showed a more diffused but 
granular distribution in comparison with parasites of the 
17X line (Fig. 2B). Diffused localization of PyEBL was 
also observed in parasites of the YM line (Fig. S3). 
Immunoelectron microscopy revealed that PyEBL 
localized in micronemes in the 17X line as reported for P. 
falciparum and Plasmodium knowlesi (9, 10). In the 17XL 
line, however, PyEBL localized not in the microneme, but 
in another microorganelle - the dense granules (12) (Fig. 
2C, Fig. S4). 
 Since there appears to be only one copy of PyEBL in 
the genomes of both lines (Fig. S5) and significant 
differences were not observed in the level of transcription 
and protein expression between the 17X and 17XL lines 
(Fig. 2A, Fig. S6), the location of EBL appears to be the 
most significant difference between them. 
 
Genetic replacement of Arg and Cys in Region 6 alters 
EBL localization. To evaluate if the Arg substitution at 
the second Cys position is responsible for the altered 
trafficking of PyEBL, we exchanged Cys and Arg in the 
17X and 17XL lines by genetic modification (17X-CtoR 
and 17XL-RtoC). The parasites were also transfected with 
control constructs which do not alter the Region 6 amino 
acid sequence (17X-CtoC and 17XL-RtoR) (Fig. 3A). 
Each of the transgenic parasites were evaluated for the 
correct integration of the constructs to the pyebl gene locus 
by specific PCR analysis followed by sequencing of the 
PCR-amplified products (not shown) and Southern blot 
analysis (Fig. 3B). 
 In the 17X line, replacement of Cys with Arg 
(17X-CtoR) altered the PyEBL localization from an apical 
pattern to a non-apical diffused pattern and PyEBL did not 
colocalize with AMA1. Furthermore, the replacement of 
Arg with Cys in the 17XL line (17XL-RtoC) altered the 
PyEBL localization from a non-apical diffused pattern to 
an apical pattern. Control parasites did not display altered 
PyEBL localization (Fig. 4). These results confirm that the 
observed substitution from Cys to Arg is responsible for 
the altered localization of PyEBL from micronemes to 
dense granules in the 17XL line. 
 
EBL localization alters erythrocyte-type preference 
and course of infection. In order to determine if altered 
localization of PyEBL affects erythrocyte-type invasion 
preference, infected erythrocytes were examined by 
microscopy and a selectivity index (SI) was obtained by 
calculating multiple parasite infection of single 
erythrocytes for each parasite line on day 3 post-infection 
in mice (13). We found that 17XL-RtoC predominantly 
invaded reticulocytes in the same way as the non-lethal 
17X line. The SI of the 17XL line (2.38) was increased in 
17XL-RtoC (~35; P < 0.001). On the other hand, 
17X-CtoR was able to invade a variety of ages of 
erythrocytes including mature erythrocytes, comparable to 
the lethal 17XL line, with the SI of the 17X line (16.78) 
reduced in 17X-CtoR (~4; P < 0.001; Table. 1). These 
results demonstrate that the localization of PyEBL is 
responsible for the erythrocyte-type preference of the 
parasite.  
 As erythrocyte-type preference frequently correlates 
with virulence in malaria parasites, we further analyzed the 
transgenic P. yoelii parasites for differences in the course 
of infection and survival of parasite-infected mice. Mice 
infected with the 17XL-RtoC line developed significantly 
lower parasitemias compared with the parental 17XL and 
control 17XL-RtoR lines (Fig. 5A) with 100% survival 
(Fig. 5C), whereas all mice infected with 17XL and 
17XL-RtoR lines died by day 7 (Fig. 5C). The pattern 
observed for the 17XL-RtoC line was identical to that 
observed for the non-lethal 17X line. Thus, trafficking of 
PyEBL to the micronemes causes the virulence of the 
17XL line to be reduced to the same level as the non-lethal 
17X line, suggesting that PyEBL is a critical virulence 
determinant in the 17XL line. The parasitemia of mice 
infected with 17X-CtoR increased significantly compared 
to those infected with parental 17X and control 17X-CtoC 
lines during the acute phase of infection on days 4 to 5 (P 
< 0.001). However, the parasitemia did not reach the level 
observed for the lethal 17XL line, and reduced to the same 
level observed for the 17X and 17X-CtoC lines by day 9 
(Fig. 5B). No parasites were detectable by microscopy at 
day 17 (not shown). This suggests that the 17X-CtoR line 
is able to invade a greater repertoire of erythrocyte types 
than 17X, but is unable to invade as many types as the 
17XL line. This reduced capacity to invade multiple 
erythrocyte types compared to the 17XL line results in a 
non-lethal infection, in which all mice survive (Fig. 5C). 
Thus, displacement of the EBL from microneme was not 
sufficient to make this line fully lethal, suggesting the 
existence of other determinant(s). 
 
Discussion 
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 The results of this study indicate that replacement of 
Cys to Arg at the second Cys position of PyEBL Region 6 
is the major determinant of the difference between lethal 
and non-lethal lines of P. y. yoelii parasites. This 
substitution alters the intracellular organelle localization of 
PyEBL from the micronemes to the dense granules, and 
alters the erythrocyte-type invasion preference, course of 
infection and parasite virulence in the host. 
 The crystal structure of Region 6 of P. falciparum 
EBA-175 indicates that the second Cys residue forms a 
disulfide bridge with the fourth Cys residue in this region. 
Arg substitution of the second Cys residue in the P. yoelii 
17XL line abolishes this disulfide bridge, and thus likely 
destroys the Region 6 structure which is critical for the 
trafficking of the protein to the micronemes. It is possible 
that incorrectly folded Region 6 would not allow the 
protein to be properly recognized by an (as yet 
uncharacterized) partner molecule responsible for the 
trafficking of the EBL protein to the micronemes (9). The 
mechanism involved in the trafficking of the mutated 
protein to the dense granules remains unresolved. 
 Using genetic modification, we have demonstrated 
that when PyEBL is trafficked to the microneme in the 
17XL line genetic background, the erythrocyte-type 
invasion preference and the course of infection are 
comparable with those of the non-lethal 17X line. This 
indicates that the substitution of Cys to Arg is a major 
determinant of the lethal phenotype of the 17XL line. 
However, when PyEBL was not trafficked to the 
microneme in parasites with the 17X line genetic 
background, the course of infection was intermediate 
between the two parental lines, suggesting that although 
PyEBL is a critical determinant, other factor(s) are also 
involved in the lethal phenotype of the 17XL line. In P. 
falciparum, the expression of EBL appears to be 
co-operationally regulated with another Plasmodium 
ligand encoded by the rbl (reticulocyte-binding-like) 
multigene family that is composed of 6 members in P. 
falciparum and at least 14 members in P. yoelii (14 - 16), 
thus the P. yoelii rbl protein, Py235, is a potential 
candidate for such factor(s). Consistent with this 
hypothesis is the finding that when Py235 expression was 
suppressed, the course of infection of the lethal P. yoelii 
YM line was altered from a lethal pattern to an 
intermediate pattern similar to that observed in the 
17X-CtoR line shown in this study (17). Based on these 
observations, we propose that PyEBL may preferentially 
recognize reticulocytes and that the removal of PyEBL 
from the micronemes may result in free space within this 
organelle that may subsequently be filled with other 
ligand(s), possibly Py235, which consequently enables the 
parasite to invade a variety of erythrocyte types. As 
different Py235 proteins may have different 
receptor-specificities, parasite invasion preference and the 
subsequent course of infection may vary, depending on the 
Py235 member that fills the free space in the micronemes 
created by the absence of PyEBL. Such a switching 
mechanism for an erythrocyte invasion pathway has been 
previously proposed for P. falciparum (18). 
 A Linkage Group Selection analysis conducted by 
Pattaradilokrat et al [submitted together with this 
manuscript] identified a chromosomal region which 
included the ebl gene locus as a major determinant in the 
multiplication rate differences between the lethal P. y. 
yoelii YM line and a non-lethal 33X line, supporting the 
role of the EBL protein in controlling virulence 
phenotypes. Consistent with our findings that another 
genetic factor may be involved, they also identified a 
further genomic region on P. yoelii chromosome 5 or 6 
that showed weak association with multiplication rate. 
 As PyEBL localized in the dense granules is 
potentially non-functional, we attempted to disrupt the 
pyebl gene locus in both the 17X and 17XL lines (Fig. S7). 
However, repeated attempts failed to achieve this, despite 
the successful genomic integration of the control plasmid. 
This indicates PyEBL is essential for parasite survival 
even when it is not trafficked to the microneme. Two 
possible explanations for this may be; an undetectable 
amount of PyEBL may still localize in the micronemes and 
remain functional, or PyEBL is functional during 
erythrocyte invasion (or for another unknown critical role 
during the life cycle) even when localized in the dense 
granules. Although a subgroup of the dense granules, 
known as exonemes, were recently reported to secrete their 
contents immediately prior to schizont rupture (19), we 
found that PyEBL was not detected on the surface of 
released individual merozoites of 17XL parasites (Fig. S8). 
Thus, the identity of the PyEBL-containing dense granules 
and the timing of PyEBL secretion from them, if at all, in 
the 17XL line remain undetermined. 
 In summary, we have found that a single nucleotide 
substitution altered the intracellular localization of the 
malaria parasite ligand PyEBL, which in turn altered 
erythrocyte invasion preference, course of infection, and 
parasite virulence. The virulence-mediating mechanism 
described in this report furthers our understanding of 
parasite-host interactions, and has important implications 
for malaria vaccine design especially those based on 
PvDBP for P. vivax malaria. 
 
Materials and Methods 
 
Rodent malaria parasites. Plasmodium yoelii 17X, 17XL, 
and YM lines were maintained in BALB/c mice (Charles 
River Japan Inc., Japan). P. yoelii YM line was a kind gift 
from David Walliker, Edinburgh University, UK. 
 
DNA and RNA isolation. Parasite genomic DNA (gDNA) 
was isolated from parasite-infected mouse blood using 
DNAzol BD reagent (Invitrogen, Carlsbad, CA). 
Parasite-infected blood was passed through one CF11 
cellulose column to remove leukocytes and a 
schizont-enriched fraction was collected by differential 
centrifugation on a 50% Percoll™ solution (GE Healthcare, 
Buckinghamshire, UK). Total RNA was isolated from the 
schizont-enriched fraction using RNeasy Mini Kit 
(QIAGEN, Germany). Complementary DNA (cDNA) was 
synthesized using Omniscript reverse transcriptase 
(QIAGEN) with random hexamer after DNAse treatment.  
 
PCR amplification and sequencing of ebl genes. ebl 
genes were PCR-amplified from gDNA using KOD Plus 
DNA polymerase (TOYOBO, Japan) with specific primers 
for each ebl gene designed using the P. yoelii genome 
database (The Institute for Genomic Research website) and 
the P. chabaudi and P. berghei genome project' databases 
(The Sanger Centre website). ebl sequences were 
determined by direct sequencing using an ABI PRISM® 
310 genetic analyzer (Applied Biosystems, Foster City, 
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CA) from PCR-amplified products. Sequences were 
aligned in CLUSTALW implemented in MacVector (ver. 
9.0; Accelrys, Inc., San Diego, CA). 
 
Southern blot analysis. Five micrograms of P. yoelii 
gDNA were digested with EcoRI, EcoRV, ClaI, BanI and 
NspI, and BanI and HpaI with appropriate buffer overnight. 
Digested gDNA was subjected to electrophoresis on 0.8% 
agarose gels, followed by alkaline transfer onto a 
Hybond-N+ PVDF membrane (GE Healthcare). Probes 
were firstly PCR-amplified with 
5'–TAAATCTAAATGGGATACAT–3' and 
5'–AGTTGGATTGATAGTTACAGATTC–3' primers for 
the pyebl region (Pr), cloned into pGEM-T Easy® plasmid 
(Promega, Madison, WI), digested from the plasmid, and 
then hybridized onto membranes. Probes were labeled with 
the AlkPhos Direct kit (GE Healthcare) and a 
chemi-luminescenct signal developed with CDP-star 
reagent (GE Healthcare) was recorded on RX-U film 
(FUJI-FILM, Japan).  
 
Recombinant proteins. Expression plasmids were 
constructed based on the pEU-E01-G(TEV)-N2 vector 
(20) by inserting PCR products amplified from P. yoelii 





C–3' for PyEBL regions 1 to 6 (R1-6; amino acid positions 
















AGAACTACAG–3' for the 19-kDa region of the 
merozoite surface protein 1, PyMSP1 (PyMSP1-19; 1658 
– 1757). The stop codon is shown in bold letters and XhoI 
and BamHI restriction sites are underlined. Glutathione 
S-transferase (GST)-fused PyEBL or PyMSP1-19 
recombinant proteins were expressed using the wheat germ 
cell free protein synthesis system (Protemist DT, CellFree 
Sciences, Matsuyama, Japan). Recombinant proteins were 
captured by a glutathione column, washed, and eluted with 
glutathione elution buffer. Protein synthesis was confirmed 
by SDS-PAGE and Coomassie Brilliant Blue protein 
staining. Recombinant PyEBL R1-6 and R3-5 and 
PyMSP1-19 were used to produce antibodies and PyEBL 
R1-2, and R2 were used for Western blot analysis.  
 
Antibodies. To produce mouse anti-PyEBL and 
anti-PyMSP1 sera, female BALB/c mice were 
intraperitoneally immunized 5 times with recombinant 
PyEBL R1-6 or 3 times with recombinant PyMSP1-19 
emulsified with Freund's adjuvant, and sacrificed for 
serum collection. To produce rabbit anti-PyEBL R3-5 
serum, a female Japanese white rabbit was subcutaneously 
immunized 3 times with recombinant PyEBL R3-5 
emulsified with Freund's adjuvant. To produce mouse 
anti-PyEBL monoclonal antibodies, the spleen was 
removed from a mouse immunized with recombinant 
PyEBL R1-6 and spleen cells were fused with a mouse 
myeloma cell line derived from a BALB/c mouse by 
conventional polyethylene glycol method. Supernatants of 
cultured hybridoma colonies were tested with recombinant 
PyEBL R1-6 by enzyme-linked immunosorbent assay and 
on P. yoelii 17 X blood smears by indirect 
immunofluorescent assay. Positive hybridoma colonies 
were selected and cloned by two rounds of limiting 
dilution. The epitope region of each monoclonal antibody 
was tested by Western blot with a panel of recombinant 
PyEBL proteins. Anti-AMA1 rabbit serum was a gift from 
Carole Long, National Institutes of Health, USA. 
 
Immunofluorescence microscopy. P. yoelii-infected 
mouse erythrocytes were smeared onto glass slides, air 
dried and stored at –80˚C without fixation. Slides were 
thawed, acetone-fixed, preincubated with PBS containing 
5% non-fat milk at 37˚C for 30 min, incubated with mouse 
anti-PyEBL and rabbit anti-AMA1 sera at room 
temperature for one hour, and then incubated with 
fluorescein isothiocyanate (FITC)-conjugated goat 
anti-(mouse IgG and IgM) antibody (Biosource Int., 
Camarillo, CA) and Alexa-546 conjugated goat anti-rabbit 
IgG antibody (Molecular Probes, Eugene, OR) at 37˚C for 
30 min. Parasite nuclei were stained with 
4',6-diamidino-2-phenylindole (DAPI). Differential 
interference contrast (DIC) and fluorescent images were 
obtained using a fluorescence microscope (BX50; 
Olympus, Japan) with a CCD digital camera (DC500; 
Leica, Germany), and processed using Adobe Photoshop 
CS (ver. 8.0; Adobe Systems Inc., San Jose, CA). 
 
Immunoelectron microscopy. P. yoelii-infected mouse 
blood was fixed in 1% paraformaldehyde–0.1% 
glutaraldehyde in Hepes-buffered saline, and embedded in 
LR white resin (Polysciences, Inc., Warrington, PA). 
Sections were blocked for 30 min in PBS-milk-Tween 20, 
incubated overnight at 4˚C in PBS-milk-Tween 20 
containing mouse anti-PyEBL R1-6 serum, and then 
incubated for 1 hour in PBS-milk-Tween 20 containing 
goat anti-mouse IgG conjugated with gold particles (10 nm 
diameter; Jansen, Piscataway, NJ). Sections were stained 
with 2% uranyl acetate in 50% methanol and examined by 
electron microscopy (JEM-1230; JEOL, Japan). 
 
Genetic modification of the pyebl gene locus. Two basic 
plasmids, pPbDT3U-B12 and pHDEF1-mh-R12, were 
constructed. A DNA fragment encoding cyan fluorescent 
protein (CFP) was PCR-amplified from pECFP-C1 
plasmid (Stratagene) using KOD Plus DNA polymerase 
with primers 
5'–agcGCTAGCGTGAGCAAGGGCGAG–3' (NheI site is 
underlined) and 
5'–gacGTCGACGGATCCTCTAGACTTGTACAGCTC
GTCC–3' (SalI and XbaI sites are underlined and BamHI 
site is shown in bold), and ligated into the pGEM-T Easy 
plasmid. The insert was then digested with NheI and SalI, 
purified, and ligated into pRGDT-B12 (21) using the NheI 
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and SalI sites, yielding pRCDT-B12. pRCDT-B12 was 
digested with ClaI and XbaI and filled with a 
oligonucleotide linker comprising 
cgatCTCGAGCCCGGGt and 
ctagaCCCGGGCTCGAGat to generate XhoI (underlined) 
and SmaI (bold) sites to yield pPbDT3U-B12. 
pHDEF1-mh (22) was digested with SmaI and ApaI to 
remove the 3' untranslated region of histidine rich protein 
2, the ApaI cohesive end was blunted and a Gateway gene 
conversion cassette C1 (Invitrogen) was inserted. The XhoI 
site was destroyed by XhoI-digestion, filled-in using KOD 
Plus DNA polymerase, and self-ligated to yield 
pHDEF1-mh-R12. 
 To modify the pyebl gene locus, a DNA fragment 
encoding PyEBL region 6 to the stop codon was 





(NcoI and XhoI sites are underlined) and cloned into 
pGEM-T Easy® plasmids. The insert was ligated into the 
NcoI and XhoI sites of pPbDT3U-B12 to yield 
pR6Cyt-B12. DNA fragments encoding PyEBL region 3 to 
the stop codon were PCR-amplified from cDNA of P. 
yoelii 17X and 17XL lines with primers 
5'–atCTTCTGTTAAACCCAGTAATAC–3' and 
5'–ccAGATCTTTAATAAAAATCTACAGGTATATATT
C–3' (BglII site is underlined). PCR products were then 
ligated into the SmaI site of pR6Cyt-B12, yielding 
pR6Cyt+R3Cyt(X)-B12 and pR6Cyt+R3Cyt(XL)-B12, 
respectively. pR6Cyt+R3Cyt(X)-B12 and 
pR6Cyt+R3Cyt(XL)-B12 were subjected to a BP 
recombination reaction with the donor vector 
pDONR™221 (Invitrogen) to produce the corresponding 
entry plasmids pENT.R6Cyt+R3Cyt(X) and 
pENT.R6Cyt+R3Cyt(XL). These entry plasmids were 
subjected to a LR recombination reaction (Invitrogen) 
according to the manufacturer's instructions with 
pHDEF-1-mh-R12 to yield replacement constructs 
pYEBL-R6Cyt+R3Cyt(X) and 
pYEBL-R6Cyt+R3Cyt(XL), respectively. 
 P. yoelii schizont-enriched fraction was collected by 
differential centrifugation on 50% HistoDenz in PBS and 
20 µg of XhoI-digested transfection constructs were 
electroporated to 5 × 107 of enriched schizonts using the 
Nucleofector™ device (Amaxa GmbH, Germany) with 
Human T cell solution under program U-33 (23). 
Transfected parasites were intravenously injected into 
8-weeks-old BALB/c female mice, which were treated by 
intraperitoneal injection with 1 mg/kg of pyrimethamine 
daily. Before inoculation of 17X line parasites, mice were 
treated with phenylhydrazine to increase the reticulocyte 
population in the blood. Drug resistant parasites were 
cloned by limiting dilution. Integration of the transfection 
constructs was confirmed by PCR-amplification with a 
unique set of primers for the modified pyebl gene locus 
followed by sequencing, and Southern blot analysis. 
 
Course of infection. To assess the course of infection of 
transgenic and wild type parasite lines, 1 × 106 parasitized 
erythrocytes were injected intravenously into 8-week-old 
female BALB/c mice. Thin blood smears were made daily, 
stained with Giemsa’s solution, and parasitemias were 
recorded. Mouse survival was evaluated by the 
Kaplan-Meier method. Parasitemias of each group were 
compared by one-way ANOVA test and Tukey's post test 
implemented in Prism4.0 (GraphPad Software, San Diego, 
CA). 
 
Selectivity index. To compare erythrocyte preference 
between transgenic and wild type P. yoelii parasite lines, a 
selectivity index was calculated as follows; 
multiple-infected erythrocytes divided by the expected 
number of multiple-infected erythrocytes, which was 
calculated from the number of infected erythrocytes and 
parasitemia (13). When the preferred erythrocyte type is 
limited, the observed number of multiple-infected 
erythrocytes increases. More than 200 parasitized 
erythrocytes were examined on Giemsa-stained thin blood 
smears collected on day 3 post-inoculation. The selectivity 
index of each group was compared by one-way ANOVA 
test and Tukey's post test implemented in Prism4.0. 
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Figure 1. Schematic structure of P. yoelii EBL (PyEBL). 
SIG, TM, R2 and R6 indicate the putative endoplasmic 
reticulum transporting signal, the transmembrane region, 
Region 2 and Region 6. Amino acid alignment of PyEBL 
from 17X, 17XL and YM lines are shown below. Eight 
conserved Cys residues that form disulfide bridges 
(Predicted SH-bond) and the substitution from Cys to Arg 
(*) are indicated. 
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Figure 2. Western blot analysis and PyEBL localization 
in P. yoelii schizont by immunostaining. (A) Western 
blot analysis with monoclonal antibodies (mAb) 5B10 
(lane 1), mAb 1G10 (lanes 2) and mouse serum (lane 3) 
specific for PyEBL against purified P. yoelii schizont 
extracts. A 110-kDa band was detected in both 17X and 
17XL lines with no significant difference in the protein 
expression level (arrowhead). This band was not detected 
by normal mouse serum (lane 4). Anti-AMA1 serum 
detected 66-kDa band in the similar level (lane 5). (B) P. 
yoelii schizonts were incubated with mAb 5B10 (α-EBL), 
rabbit anti-AMA1 serum (α-AMA1), and DAPI (blue) for 
nuclear staining. Schizonts labeled with anti-PyEBL 
(5B10) were stained with FITC secondary antibody 
(green). Anti-AMA1 were stained with Alexa-546 
secondary antibody (red). Differential interference contrast 
(DIC) images are shown in the right-hand column. 17X 
line shows apical PyEBL signal co-localized with AMA1, 
but region 6 substituted 17XL line shows diffused staining 
that does not co-localize with AMA1. (C) Immunoelectron 
microcopy was carried out for resin-embedded P. yoelii 
17X and 17XL lines with anti-PyEBL mouse serum and 
secondary antibody conjugated with gold particles. PyEBL 
was detected in the micronemes (arrowheads) of the 17X 
line, but in the 17XL line, it was located in the dense 
granules (arrows). N, Mn, DG and Rh indicate nucleus, 
microneme, dense granule and rhoptry. 
 
Figure 3. Amino acid replacement of PyEBL region 6 
second cysteine location by targeted recombination. (A) 
Schematic representation of the wild-type (WT) and 
modified (TG) pyebl gene loci. The replacement cassette 
(Insert) was inserted into the pyebl gene locus by double 
crossover recombination. In this schematic, the second Cys 
in Region 6 was replaced with Arg in the 17X line to 
generate 17X-CtoR. Other transgenic lines were generated 
in a similar fashion. ClaI restriction sites and the expected 
size of the DNA fragment following ClaI digestion are 
shown. "Pr" indicates a probe region used in Southern blot 
analysis. (B) Southern blot analysis of the pyebl gene locus 
in WT and transgenic parasite lines derived from P. yoelii 
17X and 17XL. The absence of the 4.2-kb WT band and 
the presence of an 11.1-kb band indicate that the PyEBL 
locus was modified in all transgenic clones. 
 
 
Figure 4. Replacement of Cys to Arg in Region 6 
altered subcellular localization of PyEBL. Schizonts of 
transgenic parasite lines were incubated with mAb 5B10 
(α-EBL), rabbit anti-AMA1 serum (α-AMA1), and DAPI 
(blue) for nuclear staining. DIC images are shown in the 
right-hand column. In 17X background, control (C to C) 
Otsuki et al. -8- 
shows apical PyEBL signal co-localized with AMA1, but 
replaced (C to R) shows 17XL pattern. Inversely, 17XL 
background control (R to R) shows diffused non-apical 
pattern, but replaced to cysteine (R to C) shows apical and 
co-localized with AMA1. 
 
 
Figure 5. Effect of the alteration of pyebl gene loci on the 
course of infection and parasite virulence in mice. Mice 
were intravenously inoculated with 1 × 106 parasitized 
erythrocytes from wild type or transgenic parasite lines. 
(A) Parasitemia of 17XL-RtoC was dramatically reduced 
to the same level as that of the non-lethal 17X line. (B) 
Parasitemia of 17X-CtoR was significantly higher than 
parental 17X and control 17X-CtoC on days 4 and 5 (P 
<0.001), the acute phase of infection, however the pattern 
observed is intermediate between the lethal 17XL and 
non-lethal 17X lines. Parasitemias are plotted using the 
geometric mean and standard deviation of log-transformed 
data from groups of 5 mice. (C) All mice infected with 
17XL-RtoC survived whereas all mice infected with 
parental 17XL and control 17XL-RtoR lines died by day 7. 





TABLE 1. Selectivity index of wild type and transgenic Plasmodium yoelii lines. 
 
Parasite n Selectivity Index (range) 
 
17X-CtoR #1 5 3.87 (1.86 - 5.32) 
17X-CtoR #2 5 4.25 (2.38 - 7.97) 
17X-CtoC 5 23.53 (16.49 - 36.00) 
17X 5 16.78 (7.60 - 24.99) 
 
17XL-RtoC #1 5 34.35 (29.18 - 38.05) 
17XL-RtoC #2 5 35.99 (29.97 - 42.72) 
17XL-RtoR 5 1.31 (0.57 - 2.13) 
17XL 5 2.38 (1.58 - 3.75) 
 
Selectivity indices were calculated from parasitized Giemsa stained thin blood films 
collected from each infection. 
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Supplementary Materials and Methods 
 
Quantification of pyebl and pyama1 transcripts. To 
quantify and compare pyebl transcription levels between 
17X and 17XL, real-time PCR was carried out under the 
following conditions; five BALB/c mice were infected 
with P. yoelii intraperitoneally and parasites were collected 
on day 5 by cardiac puncture. Total RNA was isolated 
from each mouse independently and cDNA was generated 
from the schizont enriched fraction. Real-time PCR was 
carried out  using the QuantiTect™ SYBR® Green PCR 
Kit (QIAGEN) with 
5'–TGAATCTTTCCAATCTTTCCC–3' and 
5'–CCATGTCTCTCCGTTTTCAATG–3' primers for 
pyebl or with 5'–GAAAAGGTGCATGGTTCTGG–3' and 
5'–GAAAAGGTGCATGGTTCTGG–3' primers for 
pyama1 using the LightCycler® system (F. Hoffmann-La 
Roche Ltd., Basel, Switzerland). Copy number of pyebl 
and pyama1 were determined using a standard curve 
generated by serially diluted plasmids containing the target 
insert sequence.  
 
SDS-PAGE and Western blot analysis. Parasite-infected 
blood was passed through a CF11 cellulose column to 
remove leukocytes and a schizont-enriched fraction was 
collected by differential centrifugation on a 50% Percoll 
solution. Schizont proteins were first extracted by repeated 
freezing-thaw cycles in phosphate buffered saline (PBS) 
containing protease inhibitors [PI; 1 µg/mL of leupeptin, 1 
µg/mL of pepstatin A, 100 µM 4-(2-aminoethyl) 
benzenesulfonyl fluoride hydrochloride] and 1 mM EDTA 
(ethylenediaminetetraacetic acid), followed by extraction 
of the insoluble pellet in 1% Triton X-100 in PBS-PI. 
Triton X-100 soluble proteins, containing PyEBL and 
PyAMA1, were incubated with 6% β-mercaptoethanol at 
100˚C for 3 min, and subjected to electrophoresis on a 
5–20% polyacrylamide gel (ATTO, Japan).  Proteins 
were then transferred to a Immuno-Blot PVDF membrane 
(Bio-Rad, Hercules, CA), immunostained with mouse 
serum or monoclonal antibodies followed by horseradish 
peroxidase-conjugated goat anti-(mouse IgG Fc) antibody 
(The Jackson laboratory, Bar Harbor, ME), and visualized 
with Immobilon™ Western Chemiluminescent HRP 
substrate (Millipore, Billerica, MA). Images were captured 
on RX-U film.  
 
Live staining of P. yoelii free merozoites. Parasitized 
erythrocytes collected from mice were suspended in 
RPMI1640 medium containing 20%  fetal calf serum 
(complete medium) and incubated at 24˚C for 13 hours for 
schizont maturation. Schizonts were then enriched by 
differential centrifugation on 50% HistoDenz (Sigma, St. 
Louis, MO) in PBS at 2,500 rpm for 12 min. Collected 
parasites were passed through a 29G syringe needle 5 
times, suspended in 500 µl of RPMI1640 complete 
medium, and then incubated at 37˚C for 2 min. Parasites 
were washed, incubated in RPMI1640 complete medium 
containing rabbit anti-PyEBL R3-5 and mouse 
anti-PyMSP1-19 sera at room temperature for 30 min, 
washed again, and smeared on glass slides. Air dried 
smears were fixed in ice-cold acetone, and incubated with 
Alexa-488 conjugated goat anti-rabbit IgG antibody 
(Molecular Probes) and Alexa-546 conjugated goat 
anti-mouse IgG antibody. Parasite nuclei were stained with 
DAPI. Images were captured as described above. 
 
Knock-out strategy of the pyebl gene locus. To 
knock-out the pyebl gene locus, a DNA fragment from the 
5' side of pyebl was PCR-amplified from gDNA of the P. 
yoelii 17XL line with primers 
5'–ACCAAATGCATAGAGTTTTA–3' and 
5'–AAATTGATTCTTCTACTTGGTATG–3'. PCR 
products were then ligated into SmaI site of pR6Cyt-B12, 
yielding pR6Cyt+5U-B12, which was processed in a 
similar manner as described above to yield knock-out 
construct pYEBL-KO. 
 
Supplementary Figure legends 
 
 
Figure S1. Alignment of the deduced amino acid 
sequence of Plasmodium EBL region 6. Cys residues 
are highlighted and numbered. P.y., Plasmodium yoelii; 
PkDBPα, -β, and -γ (M90466, M90694, and M90695, 
respectively), Plasmodium knowlesi Duffy Binding 
Proteins; PvDBP (DQ156512), Plasmodium vivax DBP; 
PfEBA-175 (M93397), PfJESEBL (AB080796), 
PfBAEBL (AF332918), PfPEBL (DQ100425), and 
PfEBL1 (AF131999), Plasmodium falciparum EBLs. 
Nucleotide sequences for P. y. yoelii EBL 17XL line 
(AB430781), YM line (AB430783),17X line (AB430782), 
33X line (AB430784), and 33XPr3 line (AB430785), P. y. 
nigeriensis EBL (AB430786), P. berghei EBL (ANKA 
line, AB430787), P. chabaudi EBL (AB430788), and P. 
vinckei EBL (AB430789) are deposited in DDBJ. The 
number and location of Cys residues in region 6 are 
conserved among 17 EBL proteins except P. yoelii 17XL 
and YM lines, and PfEBL-1. The transcription of 
PfEBL-1 has been shown to below, the transcription 
pattern throughout the asexual life cycle was distinct from 
other members, and protein expression has not been 
observed to date. P. yoelii 33X, 33XPr3 and YM lines are 
kind giftsfrom D. Walliker. Peliminary sequence data for 
P. berghei, P. chabaudi and P. vinckei were obtained from 
The Institute for Genomic Research (http://www.tigr.org). 
Nucleotide sequence data reported in this paper are 
available in the GenBank™/EMBL/DDBJ databases 
under the accession numbers: AB430781 – AB430789. 
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Figure S2. Recombinant EBL proteins and anti-PyEBL 
antibodies. (A) Schematic representation of a panel of 
glutathione S-transferase (GST)-fused PyEBL recombinant 
proteins used for immunization and/or epitope mapping of  
antibodies. SIG, predicted signal peptide sequence; TM, 
transmembrane region; cyt, cytoplasmic region; R1, R2, 
R3-5, and R6 indicate PyEBL regions 1 to 6. (B) Epitope 
mapping of antibodies. Western blot analysis showed that 
monoclonal antibodies (mAb) 1G10  and 5B10 reacted 
with GST-PyEBLR1-6 and GST-PyEBLR3-5, indicating 
that the epitope was located in PyEBL region R-5. Mouse 
anti-PyEBLR1-6 serum (Mo α-R1-6) reacted with all 
recombinant PyEBL proteins. 
 
 
Figure S3. Subcellular localization of EBL in 
Plasmodium yoelii YM line. P. yoelii YM line schizonts 
were incubated with mAb 5B10 (α-EBL; FITC, green), 
rabbit anti-AMA1 serum (α-AMA1; Alexa-546, red), and 
DAPI (blue) for nuclear staining.  Differential 
interference contrast (DIC) images are shown in the 
right-hand panel. EBL did not co-localize with AMA1 in 
the YM line, similar to the observation in 17XL line. 
 
 
Figure S4. Further immunoelectron microscopy images. 
PyEBL was detected in the micronemes (arrowheads) in 
the 17X line, however, it was detected in the dense 
granules (arrows) in 17XL line. N, Mn, DG and Rh 
indicate nucleus, micronemes, dense granules and 
rhoptries. 
 
Figure S5. pyebl is a single copy gene. (A) Schematic of 
the pyebl gene locus (not to scale). Restriction sites and 
the expected size of the DNA fragment by enzyme 
digestion are shown. “Probe” indicates the probe region 
used in Southern blot analysis. (B) Southern blot analysis 
of the pyebl gene locus in 17X and 17XL lines. 
Hybridization of pyebl probe detected only a single band 
from EcoRI- or EcoRV-digested DNA and only two 
bands from BanI/HpaI- or BanI/NspI-digested DNA. If 
the P. yoelii genome possesses more than a single copy of 
pyebl, additional bands are likely to be observed.  Taken 
together with the fact that only a single copy of the pyebl 
gene can be found in the P. yoelii (17X line) genome 
database (5-fold coverage), this result strongly suggests 




Figure S6. Quantitative comparison of PyEBL 
transcription. No significant difference between 17X 
and 17XL in the relative transcript number of pyebl 
against ama1 quantified by real-time RT-PCR (n = 5). 
The bars indicate median values.  
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Figure S7. Knock-out strategy of the pyebl gene locus. 
Schematic of the wild-type (WT) and knock-out (KO) 
pyebl gene loci. The knock-out cassette (Insert) would be 
inserted into the pyebl gene locus by double crossover 
recombination and disrupts gene function. A total of 4 
attempts to disrupt the pyebl gene locus were performed in 
17X and 17XL lines (twice for each) without success. As a 
control, replacement plasmids, pYEBL-R6Cyt+R3Cyt(X) 
and pYEBL-R6Cyt+R3Cyt(XL), were simultaneously 
transfected and genomic integration of these plasmids was 
always obtained. 
 
Figure S8. PyEBL was not expressed on the released 
merozoite surface. Live merozoites of P. yoelii 17X and 
17XL lines were incubated with rabbit anti-PyEBL R3-5 
serum (α-EBL) and mouse anti-PyMSP1-19 serum 
(α-MSP1), followed by secondary antibodies conjugated 
with fluorescent Alexa dyes and DAPI for nuclear 
staining. Differential interference contrast (DIC) images 
are shown in the right-hand column. MSP1 was detected 
on the merozoite surface, but EBL was not. 
Anti-PyMSP1-19 serum was produced by N. 
Kangwanrangsan, Ehime University. 
 
 
 
